Possibilities of Correction of Functional Diseases of the Gastrointestinal Tract in Patients with Anxiety Disorders

References

1. Beck A., Freeman A. Cognitive psychotherapy of personality disorders. St. Petersburg: Peter, 2019. 448 p.
2. Boraeva, T. T., Vadaeva, M. A., Matveeva, U. V., Revazova, A. B., Albegova, B. Z., Kanukoeva, D. T., Mishvelov, A. E. and Povetkin, S. N. Dynamics of Diseases of the Upper Digestive Tract in Children, Journal of Pharmaceutical Research International, 2021; 33(38B), 48-57. doi: 10.9734/jpri/2021/v33i38B32098
3. Blinov AV, Siddiqui SA, Nagdalian AA, Blinova AA, Gvozdenko AA, Raffa VV, et al. Investigation of the influence of Zinc-containing compounds on the components of the colloidal phase of milk. Arab J Chem. 2021;14(7):103229.
4. Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016:S0016-5085(16)00223-7. doi: 10.1053/j.gastro.2016.02.032
5. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller, R. Bowel disorders. Gastroenterology. 2016;150:1393-1407.e5.
6. Khandia R. Codon Usage Analysis of Pro-Apoptotic Bim Gene Isoforms. 2022: 1711-1725
7. Maslova AY, Bazaeva KL, Abdullaeva ZA, Khazamova SO, Zeusheva KA, Grechkina TA, Semkina EN, Abramov MA, Mishvelov AE, Povetkin SN. Astrocytes and their Phenomenal Possibilities in the Treatment of Various Neurodegenerative Disorders: An Overview. Journal of Pharmaceutical Research International. 2021;33(33A): 60-68. DOI: 10.9734/jpri/2021/v33i33A31772
8. Siddiqui SA, Ali Redha A, Snoeck ER, Singh S, Simal-Gandara J, Ibrahim SA, Jafari SM. Anti-Depressant Properties of Crocin Molecules in Saffron. Molecules. 2022; 27(7):2076. DOI: 10.3390/molecules27072076
9. Firsova L.D. Generalized anxiety disorder in the practice of a gastroenterologist. Effective pharmacotherapy. 2020, 16(1): 80-83.
10. Donker, T., Griffiths, K.M., Cuijpers, P. et al. Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC Med. 2009;7,79. DOI: 10.1186/1741-7015-7-79
11. Bekhuis, Ella & Boschloo, Lynn & Rosmalen, Judith & Schoevers, Robert. Differential Associations of Specific Depressive and Anxiety Disorders with Somatic Symptoms. Journal of Psychosomatic Research. 2015; 78: 116-122. DOI: 10.1016/j.jpsychores.2014.11.007
12. Ozen D, Elif T. Symptom Similarities and Differences in Anxiety and Depressive Disorders. Psikiyatride Guncel Yaklasimlar. 2010; 2:1-15.
13. Goldberg D. Towards DSM-V: the relationship between generalized anxiety disorderand major depressive epizod. Psychol Med 2008;38:1671-1675.
14. Fedosenko S. V., Kirillova N. A. The effect of treatment of severe chronic obstructive pulmonary disease with tiotropium bromide on comorbid somatogenic anxiety-depressive disorders. Bulletin of Siberian Medicine, 2011; 10(1):92-96.
15. Mykhaylov, V., Kozhyna, H., & Zdesenko, I. Psychotherapeutic correction system of somatogenic depressive disorders in patients with cerebral stroke. INTER COLLEGAS. 2017; 3(4): 190-196
16. Vyalov S.S. Factors of the pathogenesis of functional disorders and overlap syndrome of the gastrointestinal tract. RMJ. Medical Review. 2018; 7(2):68-71.
17. Musaeva PV, et al. Creation of New Types of Medical Simulation Systems with Feedback and Interactive Guides Using Augmented and Virtual Reality: The Innovative Project. Ann Med Health Sci Res. 2021;11:S3:110-113.
18. Bledzhyants GA, Mishvelov AE, Nuzhnaya KV, Anfinogenova OI, Isakova JA, Melkonyan RS. The Effectiveness of the medical decision-making support system "electronic clinical pharmacologist" in the management of patient's therapeutic profile. Pharmacophore. 2019;10:76-81
19. Gvozdenko, A.A., Blinov, A.V., Slyadneva, K.S. et al. X-Ray Contrast Magnetic Diagnostic Tool Based on a Three-Component Nanosystem. Russ J Gen Chem 2022; 92:1153-1160. DOI: 10.1134/S1070363222060305
20. Craske, M., Stein, M., Eley, T. et al. Anxiety disorders. Nat Rev Dis Primers. 2017; 3, 17024. DOI: 10.1038/nrdp.2017.24
21. Health Quality Ontario. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment. Ont Health Technol Assess Ser. 2019;19(6):1-199
22. Wingo TS, Liu Y, Gerasimov ES, Vattathil SM, Wynne ME, Liu J, Lori A, Faundez V, Bennett DA, Seyfried NT, Levey AI, Wingo AP. Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat Commun. 2022;13(1):4314. DOI: 10.1038/s41467-022-31873-5
23. Kouba BR, Camargo A, Gil-Mohapel J, Rodrigues ALS. Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety. Int J Mol Sci. 2022 Jun 25;23(13):7077. DOI: 10.3390/ijms23137077
24. Millan MJ. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Ther Adv Psychopharmacol. 2022;12:20451253221105128. doi: 10.1177/20451253221105128
25. P?rez de la Mora M, Borroto-Escuela DO, Crespo-Ram?rez M, Rej?n-Orantes JDC, Palacios-Lagunas DA, Mart?nez-Mata MK, S?nchez-Luna D, Tesoro-Cruz E, Fuxe K. Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders. Cells. 2022;11(11):1826. DOI: 10.3390/cells11111826
26. Al-Khazali HM, Ashina H, Iljazi A, Al-Sayegh Z, Lipton RB, Ashina M, Ashina S, Schytz HW. Psychiatric Sequelae Following Whiplash Injury: A Systematic Review. Front Psychiatry. 2022 Apr 22;13:814079. DOI: 10.3389/fpsyt.2022.814079
27. Watanabe S, Omran AA, Shao AS, Xue C, Zhang Z, Zhang J, Davies DL, Shao XM, Watanabe J, Liang J. Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice. Sci Rep. 2022 Apr 7;12(1):5899. DOI: 10.1038/s41598-022-09814-5
28. Vanner S, Greenwood-Van Meerveld B, Mawe G, Shea-Donohue T, Verdu EF, Wood J, Grundy D. Fundamentals of Neurogastroenterology: Basic Science. Gastroenterology. 2016 Feb 18:S0016-5085(16)00184-0. DOI: 10.1053/j.gastro.2016.02.018
29. Grinsvall C, To?rnblom H. Tack J Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome. United European Gastroenterology Journal. 2018; 6(2): 300-309.
30. Pichugina IM, Obraztsova VS, Frolov DI. Neurogastroenterology: benefits of interdisciplinary management of patients. RMJ Medical Review. 2018; 7(2);92-96.
31. Ayivi R, Ibrahim S, Colleran H, Silva R, Williams L, Galanakis C, Fidan H, Tomovska J and Siddiqui SA. COVID-19: human immune response and the influence of food ingredients and active compounds. Bioactive Compounds in Health and Disease. 2021;4(6):100
32. Profeta A, Siddiqui SA, Smetana S, Hossaini SM, Heinz V, Kircher C. The impact of Corona pandemic on consumer's food consumption: Vulnerability of households with children and income losses and change in sustainable consumption behavior. J Verbrauch Lebensm. 2021;16(4):305-314. DOI: 10.1007/s00003-021-01341-1
33. Rzhepakovsky IV, Areshidze DA, Avanesyan SS, Grimm WD, Filatova NV, Kalinin AV, Kochergin SG, Kozlova MA, Kurchenko VP, Sizonenko MN, Terentiev AA, Timchenko LD, Trigub MM, Nagdalian AA, Piskov SI. Phytochemical Characterization, Antioxidant Activity, and Cytotoxicity of Methanolic Leaf Extract of Chlorophytum Comosum (Green Type) (Thunb.) Jacq. Molecules. 2022; 27(3):762. DOI: 10.3390/molecules27030762
34. Raevskaya AI, Belyalova AA, Shevchenko PP, Karpov SM, Mishvelov AE, Simonov AN, Povetkin SN. et al. Cognitive Impairments in A Range of Somatic Diseases Diagnostics, Modern Approach to Therapy . Pharmacophore. 2020; 11(1):136-41.
35. Galabueva AI, Biragova AK, Kotsoyeva GA, Borukayeva ZK, Yesiev RK, Dzgoeva ZG, et al. Optimization of Modern Methods of Treating Chronic Generalized Periodontitis of Mild Severity. Pharmacophore. 2020;11(1):47-51.
36. Radovanovic-Dinica B., Tesic-Rajkovica S., Grgov S. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018; 162(1):1-9.
37. Sobin WH, Heinrich TW, Drossman DA. Central Neuromodulators for Treating Functional GI Disorders: A Primer. Am J Gastroenterol. 2017;112(5):693-702. doi: 10.1038/ajg.2017.57
38. Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016 Feb 18:S0016-5085(16)00218-3. DOI: 10.1053/j.gastro.2016.02.027
39. Orsaeva AT, Tamrieva LA, Mischvelov AE, Osadchiy SS, Osipchuk GV, Povetkin SN, Simonov AN. Digital clinic "smart ward. Pharmacophore. 2020;11(1):142-146
40. Wu Y, Murray GK, Byrne EM. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun. 2021; 12:1146. DOI: 10.1038/s41467-021-21280-7
41. Akhmedov, Vadim. The development of functional gastrointestinal diseases: Genetic aspects. Terapevticheskii arkhiv. 2015; 87. 119-123. 10.17116/terarkh2015878119-123.
42. Villalba-Benito L, Torroglosa A, Luz?n-Toro B, Fern?ndez RM, Moya-Jim?nez MJ, Anti?olo G, Borrego S. ChIP-Seq-Based Approach in Mouse Enteric Precursor Cells Reveals New Potential Genes with a Role in Enteric Nervous System Development and Hirschsprung Disease. International journal of molecular sciences. 2020;21(23):9061. DOI: 10.3390/ijms21239061
43. Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cellular and Molecular Life Sciences. 2021 May;78(10):4713-33. DOI: 10.1007/s00018-021-03812-y
44. Ivashkin V.T., Shelygin Yu.A., Baranskaya E.K. Clinical recommendations of the Russian Gastroenterological Association and the Association of Coloproctologists of Russia on the diagnosis and treatment of irritable bowel syndrome. Ros journal gastroenterol hepatol coloproctol, 2017; 27(5).
45. Esaulov V.I. Treatment of anxiety-phobic disorders in patients with irritable bowel syndrome by methods of integrative psychotherapy. Modern problems of science and education. 2017;1.
46. Golovanova E.V. Functional gastrointestinal disorders: approaches to the correction of psychosomatic disorders. RMJ. 2019; 27(5):24-29.
47. Baklanov IS, Baklanova OA, Shmatko AA, Gubanova MA, Pokhilko A.D. The historical past as a factor of sociocultural transformations of postmodernity. Journal of History Culture and Art Research. 2018; 7(1):373-378
48. Baklanov I, Rodionova V, Ivashova V, Shvachkina L, Medvedeva V. Social trends for increasing satisfaction with the educational services of a Modern University. Quality-Access to Success. 2020;21(179):88-90
49. Bottelier MA, Schouw ML, Klomp A. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. BMC Psychiatry. 2014; 14, 48. DOI: 10.1186/1471-244X-14-48
50. Ilyasov KK, Demchenkov EL, Chernyshkov AS, Rodin IA, Pushkin SV, Povetkin SN, et al. Features of the phytopharmacological preparations in the metaphylaxis of urolithiasis. Pharmacophore. 2020;11(5):66-71